Perhaps timely catching HIVE Digital Technologies Ltd. (HIVE) would be a good idea

With 2.3 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.25 million shares. The 52-week range on HIVE shows that it touched its highest point at $6.84 and its lowest point at $2.75 during that stretch. It currently has a 1-year price target of $6.17. Beta for the stock currently stands at 3.60.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HIVE was up-trending over the past week, with a rise of 0.31%, but this was down by -17.31% over a month. Three-month performance dropped to -29.36% while six-month performance rose 3.90%. The stock gained 1.59% in the past year, while it has lost -29.36% so far this year. A look at the trailing 12-month EPS for HIVE yields -0.64 with Next year EPS estimates of -0.62. For the next quarter, that number is -0.14. This implies an EPS growth rate of 79.31% for this year and -6.86% for next year.

Float and Shares Shorts:

At present, 104.60 million HIVE shares are outstanding with a float of 104.07 million shares on hand for trading. On Mar 15, 2024, short shares totaled 6.08 million, which was 6.57% higher than short shares on Feb 15, 2024. In addition to JIVE as the firm’s JPMorgan International Value ET, HIVE serves as its HIVE Digital Technologies Ltd.

Institutional Ownership:

Through their ownership of 20.66% of HIVE’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HIVE since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, HIVE has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and HIVE currently yields $0.00. In the past year, HIVE’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, HIVE has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.